Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Inovalon announced the availability of its new Population Health Insights: COVID-19 Compass Dashboard.
read more
Thursday, September 21, 2017
In response to evolving industry guidelines, AMRI has assembled a medical device solutions team to help customers navigate the regulatory complexities of developing and testing medical device products.
read more
Inotiv, Inc announced today the Company’s plans to expand its St. Louis operations to provide more comprehensive and integrated services.
read more
Inotiv, Inc. announced today, an agreement to partner with Japan-based PhoenixBio Co., Ltd., to provide research services in Inotiv’s U.S. labs using PhoenixBio’s proprietary PXB-mouse® research model, a liver-humanized chimeric model used for drug ...
read more
Wednesday, November 10, 2021
Inotiv, Inc. announces the opening of its newly-constructed, scientific laboratories at its St. Louis facility.
read more
Inotiv, Inc. announced today that the Company has entered into an agreement and plan of merger with Bolder BioPATH, Inc., a contract pharmacology and pathology company.
read more
Wednesday, September 15, 2021
Inotiv, a leading contract research organization (CRO) specializing in nonclinical and analytical drug discovery and development services, and Envigo, a leading global provider of research models and services, jointly announced that they have entered...
read more
Inotiv, Inc. announced the acquisition of Histion, LLC, effective April 25, 2022. The acquisition is a strategic element of the company’s expansion of its specialized pathology services.
read more
Inotiv, Inc. announced the expansion of the company’s safety pharmacology offering with the validation and verification of a cardiopulmonary telemetry study model in cynomolgus macaques.
read more
Inotiv announced an expanded capacity to conduct Good Laboratory Practices (“GLP”) studies for in vitro cytogenetics and bacterial mutation assays as components of the Standard Battery of genetic toxicology studies required for first-in-human ...
read more
Bioanalytical Systems announced the most recent hiring related to the continued expansion of the Company’s pathology service offerings through ongoing investment and key hires.
read more
Bioanalytical Systems, doing business as Inotiv, announced I.M. Grossi, Ph.D., has joined the Company as Vice President, Toxicology.
read more
Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, announced that the Company has completed the purchase of its previously leased St. Louis facility for approximately $...
read more
Tuesday, December 03, 2019
Bioanalytical Systems, doing business as Inotiv, announced the closing of the previously announced agreement to purchase substantially all of the assets of Pre-Clinical Research Services (PCRS).
read more
Inotiv announced the acquisition of Plato BioPharma (PBI), a Colorado-based, in vivo pharmacology research and drug discovery company specializing in cardiovascular, renal, pulmonary and hepatic therapeutic areas. Transaction consideration totaled $...
read more